This guideline summary has been replaced by an updated version. Please update your bookmarks.

View the updated summary:
Epidermal growth factor receptor (EGFR) targeted therapy in stage III and IV head and neck cancer. NGC:9855

View all updated summaries in the Guideline Archive.